Cargando…
Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
BACKGROUND: Heritable pulmonary arterial hypertension (PAH) is most commonly due to heterozygous mutations of the BMPR2 gene. Based on expert consensus, guidelines recommend annual screening echocardiography in asymptomatic BMPR2 mutation carriers. The main objectives of this study were to evaluate...
Autores principales: | Montani, David, Girerd, Barbara, Jaïs, Xavier, Laveneziana, Pierantonio, Lau, Edmund M.T., Bouchachi, Amir, Hascoët, Sébastien, Günther, Sven, Godinas, Laurent, Parent, Florence, Guignabert, Christophe, Beurnier, Antoine, Chemla, Denis, Hervé, Philippe, Eyries, Mélanie, Soubrier, Florent, Simonneau, Gérald, Sitbon, Olivier, Savale, Laurent, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295506/ https://www.ncbi.nlm.nih.gov/pubmed/33380512 http://dx.doi.org/10.1183/13993003.04229-2020 |
Ejemplares similares
-
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010) -
Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022) -
An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022) -
A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016) -
Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)